NDC 50102-130-01 - CHATEAL
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 50102-130
- Requested NDC
- 50102-130-01
- Package NDCs from labels
- 50102-130-00, 50102-130-01, 50102-130-48, 50102-130-10, 50102-130-03
- Manufacturer
- Afaxys Pharma, LLC | Mylan Laboratories Limited
- Effective date
- 2021-01-27
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| CHATEAL - Afaxys Pharma, LLC | Mylan Laboratories Limited | Afaxys Pharma, LLC | Mylan Laboratories Limited | 2021-01-27 | HUMAN PRESCRIPTION DRUG LABEL |
| Chateal® (Levonorgestrel and Ethinyl Estradiol Tablets, USP 0.15 mg/0.03 mg) | RPK Pharmaceuticals, Inc. | 2020-12-15 | HUMAN PRESCRIPTION DRUG LABEL |
| National Council for Prescription Drug Programs indexing - billing unit | National Council for Prescription Drug Programs | 2013-02-13 | Indexing - Billing Unit |
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Related label |
|---|---|---|
| 50102-130-03 | 2023-02-24 | Chateal® (Levonorgestrel and Ethinyl Estradiol Tablets, USP 0.15 mg/0.03 mg) |
| 50102-130-48 | 2023-02-24 | Chateal® (Levonorgestrel and Ethinyl Estradiol Tablets, USP 0.15 mg/0.03 mg) |
| 50102-130-03 | 2023-01-30 | Chateal® (Levonorgestrel and Ethinyl Estradiol Tablets, USP 0.15 mg/0.03 mg) |
| 50102-130-48 | 2023-01-30 | Chateal® (Levonorgestrel and Ethinyl Estradiol Tablets, USP 0.15 mg/0.03 mg) |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 50102-130-00 | EA - Each | 50102-130 | dcb62401-8949-464e-ab16-85f9c6f4c40d | 1 | 2022-06-06 |
| 50102-130-01 | EA - Each | 50102-130 | b8bb767c-e280-45f7-828d-4a8aaae9c21c | 1 | 2013-02-13 |
| 50102-130-03 | EA - Each | 50102-130 | 61c25f8e-2546-4292-98d9-3172853ce2f1 | 1 | 2017-09-11 |
| 50102-130-10 | EA - Each | 50102-130 | 4a3fd139-d25f-40ed-939c-42f8b7d58d0e | 1 | 2017-09-11 |
| 50102-130-48 | EA - Each | 50102-130 | 1a4669e5-b979-4386-ba8b-04d4f4b7e28e | 1 | 2013-02-13 |
| 50102-130-90 | EA - Each | 50102-130 | 3536e405-15d6-482b-949b-31b922af726b | 1 | 2013-02-13 |
DailyMed Socrata Ingredients#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| AfterPlan | LEVONORGESTREL | SUN PHARMACEUTICAL INDUSTRIES, INC. | c30c7bc2-04fa-4590-96f5-5bcf4bba3f1a | 2018-10-26 | Warnings | 5W7SIA7YZW |
| Morning After | LEVONORGESTREL | Rapha Pharmaceuticals, Inc. | 677aa953-3c30-4ce5-e053-2991aa0ab2b2 | 2018-03-15 | Warnings | 5W7SIA7YZW |
| Levonorgestrel | LEVONORGESTREL | Novel Laboratories, Inc. | ac13a073-a33a-45f7-8483-eecc9190195f | 2017-09-15 | 5W7SIA7YZW | |
| My Way | LEVONORGESTREL | Lupin Pharmaceuticals,Inc. | ec01077e-ac3c-424a-9edc-0854fe0a2e0d | 2016-06-17 | Warnings | 5W7SIA7YZW |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.